Covid-19 first appeared at the start of December 2019. The outbreak has since become a pandemic, with over 900,000 cases confirmed worldwide and tens of thousands of deaths. In March, global equity markets fell sharply, as worries grew about the spread of the virus and the economic consequences of lockdown measures. In the year to date, US equity markets are now down by approximately 20%.
Since the beginning of 2020, equity styles (or ‘factors’) have performed in very disparate ways, as the table below shows. The relative returns of these four styles are shown versus the market index, in US dollars, as at Tuesday 31 March. We use publicly available MSCI and S&P indices.1
Momentum and low volatility displayed positive performance relative to the market, whereas small caps and high dividend (value) stocks underperformed.2 In hindsight, investors should have focused on low volatility and momentum only, in order to find some protection during the first quarter of 2020. March was particularly challenging for factors. Small tilts to small value stocks would have hurt performance significantly during the sell-off.
To understand better the performance of equity markets and factors during pandemics, we analyze the period of the Spanish flu outbreak of 1918-1919 in more detail.
To paraphrase the first sentence of Tolstoy’s Anna Karenina, all bull markets are alike (nothing bad happened), but every bear market is bearish in its own way. Each crisis is different, but perhaps history can offer some guidance. The world has experienced other pandemics in the past, most notably the ‘Spanish’ Flu of 1918-1919.
This influenza pandemic occurred in three waves throughout 1918 and 1919. The first wave began in March 1918 and lasted until the summer. The second wave was the most lethal and occurred during the fall of 1918 (October to December). It was followed by a third wave in the spring of 1919 (February). After that, the virus disappeared, probably due to improved treatments, or a mutation of the virus into a less lethal form.
During this pandemic, which spread across the globe via travelers and soldiers engaged in World War I, around 40 million people died worldwide from early spring 1918 to late spring 1919, of which 675,000 people in the United States (about 0.8% of the 1910 population).3
The pandemic occurred towards the end of World War I, a period with large economic stress and a severe market drop
During this pandemic, many businesses faced economic disruption due to a lack of available workers, temporary closure of other businesses, and a drop in demand. Moreover, the pandemic occurred towards the end of World War I, a period of widespread economic stress and a severe market correction, as highlighted below.
How did the equity market and factors behave during this period? The years around 1918 are not covered by the widely-used CRSP database, which starts in 1926. As a result, most investors ignore how factors performed during the Spanish flu outbreak period. Perhaps lessons could be drawn from this period (and other market sell-offs prior to 1926).
To answer this question, we use the data on all listed US stocks and their characteristics from Baltussen, Van Vliet and Van Vliet (2020). When studying equity styles, it is very important to correct for any size effects, since small stocks tend to be more biased and volatile and can dominate results. Also, the pre-CRSP period was characterized by many listings of small, thinly traded stocks, making it important to value-weight stock returns in order to study economic significant effects for investors. Baltussen, Van Vliet, Van Vliet (2020) therefore supplement their stock database with hand-collected data of the market capitalization of US stocks, extending the CRSP period to 1866.4
In line with Fama-French, factors are constructed by splitting all stocks in two groups: small and big, and are subsequently sorted on value (dividend yield; ‘DIV’), volatility (36-months return volatility: ‘LowVol’) and momentum (12-1 month returns; ‘MOM’) as a 2x3 sort. We will focus on the largest 50% of stocks for the equity styles. In addition, we construct the value-weighted returns on all small stocks (‘SMALL’).
As the Spanish flu occurred around World War I stocks markets were especially occupied with worries about the war. The peak of the stock market was reached in November 1916, but then sold off to bottom a year later. With the relief about the end of the war a recovery started in which the Spanish flu occurred. The figure below shows the performance of the stock market and the equity styles for the period from the stock market peak during World War I and the Spanish flu period (November 1916), to bottom (November 1917) and subsequent recovery (February 1919).
Over this period, the market dropped by about -20% from peak to bottom due to negative developments around World War I. High-dividend stocks and low volatility stocks offered protection, although not as much as in other market corrections. All stock moved in tandem and correlations went up. There was nowhere to hide. This is a bit like the recent March 2020 sell-off. After that markets recovered, with a dip around the first outbreak of the Spanish Flu.
High-dividend stocks and low volatility stocks offered protection, although not as much as in other market corrections
The markets fully recovered by the end of February 1919. During the correction, small caps underperformed, and winner stocks performed in line with the market. In the following recovery period, small caps showed the strongest performance.
Historically, epidemics and pandemics have often caused short-term equity market corrections (such was the case with SARS, MERS, the Hong Kong flu and others). As equity corrections are less rare than pandemics, it is especially interesting to take a closer look at the different equity styles during other market corrections in the pre-1926 period.
This selection of market crises include market episodes which are not often studied. This includes the 1907 Bankers’ Panic, also known as the Knickerbocker crisis5 , and also the panic of 1903, 1893, 1884, and 1873. In these six market corrections, the stock market fell by about -20% to -25%. During these periods, we see the pattern emerging of low volatility and momentum offering protection, similar to March 2020.
Intriguingly, during the recoveries that followed (the timing of which is by the way generally hard to predict) small caps and high dividend outperformed, as shown in the figure below. We also present a multi-style ‘conservative’ strategy following Blitz and Van Vliet (2018), in which low volatility, momentum and yield are combined in one strategy (‘LowVol+).6 Overall, this ‘multi-style’ strategy managed to limit losses and outperform over the correction-recovery cycle.
Pandemics are rare events, but history can give us important guidance on what to expect. Over the past centuries, pandemics emerged, like the Spanish flu (1918-1919), the Black Death (1348-1351) and others, teaching us that they come in waves, with big impact on society and markets. The case presented in this study can provide some initial insight into the impact of pandemics and market corrections on equity styles, but is by no means comprehensive. Cases and circumstances change. That said, we believe history gives guidance, as many studies reveal there is some predictability in how investors react to news. Please note that this study is not yet peer-reviewed and will be updated in the months ahead.
1We use respectively the MSCI Minimum Volatility, value-weighted, momentum, high-dividend, momentum, small cap US indices and the S&P500 low-volatility, pure value, momentum, high dividend US indices and the Russell2000 (small cap) index.
2Significant differences exist within the same style in 2020. We therefore combine (equal weight) the different style indices of MSCI and S&P and focus on the US market only.
3Garrett, T.A., 2007, Economic Effects of the 1918 Influenza Pandemic, working paper Federal Reserve Bank of St. Louis.
4Study will be available later this year including all details on the investment universe and database construction. For the 1918-1919 case study, we cover 523 US stocks for which we have market capitalization data and at least one year of returns.
This information is for informational purposes only and should not be construed as an offer to sell or an invitation to buy any securities or products, nor as investment advice or recommendation.
The contents of this document have not been reviewed by the Monetary Authority of Singapore (“MAS”). Robeco Singapore Private Limited holds a capital markets services license for fund management issued by the MAS and is subject to certain clientele restrictions under such license.
An investment will involve a high degree of risk, and you should consider carefully whether an investment is suitable for you.
Warning/Important note: This website contains information which is only available to qualified investors as defined below. If you are not a qualified investor, please click “I Disagree” to leave the website.
By clicking on "I agree", I declare that:
1 - This website may only be accessed directly or indirectly by the following persons in Singapore:
1) “institutional investor” under section 304 of the Securities and Futures Act (Cap.289)(“SFA”), which means:
(i) the Government; (ii) a statutory board as may be prescribed by regulations made under section 341 of the SFA; (iii) an entity that is wholly and beneficially owned, whether directly or indirectly, by a central government of a country and whose principal activity is (A) to manage its own funds; (B) to manage the funds of the central government of that country (which may include the reserves of that central government and any pension or provident fund of that country); or (C) to manage the funds (which may include the reserves of that central government and any pension or provident fund of that country) of another entity that is wholly and beneficially owned, whether directly or indirectly, by the central government of that country; (iv) any entity (A) that is wholly and beneficially owned, whether directly or indirectly, by the central government of a country; and (B) whose funds are managed by an entity mentioned in sub-paragraph (iii); (v) a central bank in a jurisdiction other than Singapore; (vi) a central government in a country other than Singapore; (vii) an agency (of a central government in a country other than Singapore) that is incorporated or established in a country other than Singapore; (viii) a multilateral agency, international organisation or supranational agency as may be prescribed by regulations made under section 341 of the SFA; (ix) a bank that is licensed under the Banking Act (Cap.19); (x) a merchant bank that is approved as a financial institution under section 28 of the Monetary Authority of Singapore Act (Cap.186); (xi) a finance company that is licensed under the Finance Companies Act (Cap.108); (xii) a company or co-operative society that is licensed under the Insurance Act (Cap.142) to carry on insurance business in Singapore; (xiii) a company licensed under the Trust Companies Act (Cap.336); (xiv) a holder of a capital markets services licence; (xv) an approved exchange; (xvi) a recognised market operator; (xvii) an approved clearing house; (xviii) a recognised clearing house; (xix) a licensed trade repository; (xx) a licensed foreign trade repository; (xxi) an approved holding company; (xxii) a Depository as defined in section 81SF of the SFA; (xxiii) an entity or a trust formed or incorporated in a jurisdiction other than Singapore, which is regulated for the carrying on of any financial activity in that jurisdiction by a public authority of that jurisdiction that exercises a function that corresponds to a regulatory function of the Authority under this Act, the Banking Act (Cap.19), the Finance Companies Act (Cap.108), the Monetary Authority of Singapore Act (Cap.186), the Insurance Act (Cap.142), the Trust Companies Act (Cap.336) or such other Act as may be prescribed by regulations made under section 341 of the SFA; (xxiv) a pension fund, or collective investment scheme, whether constituted in Singapore or elsewhere; (xxv) a person (other than an individual) who carries on the business of dealing in bonds with accredited investors or expert investors; (xxvi) the trustee of such trust as the Authority may prescribe, when acting in that capacity; or; (xxvii) such other person as the Authority may prescribe.
2) “relevant person” under section 305(1) of the SFA, which means:
(i) An accredited investor; (ii) a corporation the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; (iii) a trustee of a trust the sole purpose of which is to hold investments and each beneficiary of which is an individual who is an accredited investor; (iv) an officer or equivalent person of the person making the offer (such person being an entity) or a spouse, parent, brother, sister, son or daughter of that officer or equivalent person; or (v) a spouse, parent, brother, sister, son or daughter of the person making the offer (such person being an individual).
3) any person who acquires the units [in a collective investment scheme] as principal if the offer is on terms that the units may only be required at a consideration of not less than $200,000 (or its equivalent in a foreign currency) for each transaction, whether such amount is to be paid for in cash or by exchange of units in a collective investment scheme, securities, securities-based derivatives contracts or other assets, and if the following condition is satisfied: (i) the offer is not accompanied by an advertisement making an offer or calling attention to the offer or intended offer; (ii) no selling or promotional expenses are paid or incurred in connection with the offer other than those incurred for administrative or professional services, or by way of commission or fee for services rendered by any of the persons specified in section 302B(1)(d)(i) to (vi) of the SFA; and (iii) no prospectus in respect of the offer has been registered by the Authority or, where a prospectus has been registered (A) the prospectus has eAccxpired pursuant to section 299 of the SFA; or (B) the person making the offer has before making the offer 1. informed the Authority by notice in writing of its intent to make the offer in reliance on the exemption under this subsection; and 2. taken reasonable steps to inform in writing the person to whom the offer is made that the offer is made in reliance on the exemption under this subsection.
4) Or otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.
If you are not any of the types of persons described above, you are not authorized to enter this website and you should leave this website immediately.
2 Terms and Conditions
You acknowledge that you have read these Terms and Conditions (“Terms”) prior to accessing the website located at www.robeco.com/sg (“Website”) and you agree to be bound by the Terms. If you do not agree to all of the Terms, you are not an authorised user and you should not use the Website. The Website is owned by Robeco Singapore Private Limited (company registration number: UEN. 201541306Z), which is licensed by the Monetary Authority of Singapore (“MAS”) pursuant to the Securities and Futures Act (Cap.289) (“SFA”) of Singapore, and is managed by Robeco Singapore Private Limited and/or its affiliates (collectively, as “Robeco”). The Website is intended for and should be accessed by institutional investors or accredited investors (as defined under Section 4A of the SFA) of Singapore. The Website is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation or which would subject the Robeco to any registration or licensing requirement within such jurisdiction. It is your responsibility to observe all applicable laws, rules and regulations of any relevant jurisdiction. The content contained in the Website is owned by Robeco and/or its information providers and is protected by applicable copyrights, trademarks, service marks, and/or other intellectual property rights. You may not copy, distribute, modify, post, frame or link the Website, including any text, graphics, video, audio, software code, user interface, design or logos. You may not distribute, modify, transmit, reuse, repost, or use the content of the Website for public or commercial use, including all text, images, audio and/or video. Robeco may terminate your access to the Website for any reason, without prior notice. Neither Robeco, nor any of its associates, nor any director, officer or employee accepts any liability whatsoever for any loss arising directly or indirectly from the access of the Website. You agree to indemnity and hold Robeco, its associates, directors, officers or employees harmless against any and all claims, losses, liability, costs and expenses arising from your use of the Website due to violation of the Terms. Robeco reserves the right to change, modify, add or remove any parts of the Terms at any time and for any reason. The Terms shall deemed to be effective immediately upon posting. The Terms shall be governed by, and shall be construed in accordance with, the law of Singapore.
The Website has not been reviewed by the MAS. Accordingly, the Website may not be accessed directly or indirectly to persons in Singapore other than (i) to an institutional investor under Section 304 of the SFA, (ii) to a relevant person pursuant to Section 305(1), or any person pursuant to Section 305(2), and in accordance with the conditions specified in Section 305, of the SFA, or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA.
Nothing in the Website constitutes tax, accounting, regulatory, legal or investment advice. The Website is for informational purposes only and should not be construed as an offer to sell or an invitation to buy any securities or products, nor as investment advice or recommendation or for the purpose of soliciting any action in relation to Robeco’s businesses, or solicitation by anyone in any jurisdiction in which such an offer or solicitation is not authorised or to any person to whom it is unlawful to make such an offer and solicitation. Any reproduction or distribution of information from the Website, in whole or in part, or the disclosure of its contents, without the prior written consent of Robeco, is prohibited. By accessing to the Website, you agree to the foregoing.
The funds referred to in the Website are for information only. It is not a recommendation or investment advice, nor does it mean the funds is suitable for all investors. The contents of the website is not reviewed by the MAS. Any decision to participate in the funds should be made only after reviewing the sections regarding investment considerations, conflicts of interest, risk factors and the relevant Singapore selling restrictions. You should consult your professional adviser if you are in doubt about the stringent restrictions applicable to the use of the Website, regulatory status of the funds, applicable regulatory protection, associated risks and suitability of the funds to your objectives.
Any decisions made based on the information contained in the Website are the sole responsibility of yours. Any investments made or to be made shall be with your independent analyses based on your financial situation and objectives. The investments and strategies contained in the Website may not be suitable for all investors and are not guaranteed by Robeco.
Investment involves risks and may lose value. Historical returns are provided for illustrative purposes only and do not necessarily reflect Robeco’s expectations for the future. The value of your investments may fluctuate. Past performance is no indication of current or future performance. The Website may contain projections or other forward looking statements regarding future events or future financial performance of countries, markets or companies and such projection or forecast is not indicative of the future. The information contained in the Website, including any data, projections and underlying assumptions are based upon certain assumptions, management forecasts and analysis of information available on an “as is” basis and without warranties of any kind, whether express or implied, and reflects prevailing conditions and Robeco’s views as of the date published or indicated, and maybe superseded by subsequent events or for other reasons. The information contained in the Website are accordingly subject to change at any time without notice and Robeco are under no obligation to notify you of any of these changes. Robeco expressly disclaims all liability for errors and omissions in the information presented in the Website and for the use or interpretation by others of information contained in the Website.
Robeco Singapore Private Limited holds a capital markets services licence for fund management issued by the MAS and is subject to certain clientele restrictions under such licence. An investment will involve a high degree of risk, and you should consider carefully whether an investment is suitable for you.